the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

ADAMAS maintains two-year ban against Jia Xin

THE two-year ban on participation in all competitions, imposed on Ngu Jia Xin, remains in effect after the national high jump athlete was absent from the appeal proceedings held on March 18.

Anti-Doping Agency of Malaysia (ADAMAS) director, Azura Abidin, stated that no further calls would be made to the female athlete who tested positive for doping at the Malaysia Athletic Federation Track and Field Championship at the National Sports Council Mini Stadium in February 2023.

“Jia Xin submitted an appeal, however, as she did not turn up on the scheduled appeal date, we are sticking to the original decision regarding her suspension.

“We have tried to contact her, sent letters, emails, followed up, but to no avail. Even her coach can’t locate her,“ she added.

Azura spoke to reporters after the Iftar event at the Ministry of Youth and Sports here last night, which was also attended by Minister of Youth and Sports Hannah Yeoh.

Meanwhile, when contacted by Bernama today, Datuk R Annamalai, chairman of the Medical Committee of the Athletics Union of Malaysia, affirmed the continuation of the penalty against Jia Xin.

Jia Xin was suspended from all competitions from June 2 last year to June 1, 2025, following ADAMAS’ confirmation of the athlete testing positive for the banned substance sibutramine.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings